Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
11/21/2013 | WO2013170969A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano'[3,4,b]indol]-4-amine and paracetamol or propacetamol |
11/21/2013 | WO2013170966A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and a gabapentinoid |
11/21/2013 | WO2013170965A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and antidepressants |
11/21/2013 | WO2013170741A1 Benzodioxane compound, composition comprising same and use thereof |
11/21/2013 | WO2013170738A1 Agomelatine acid radical composite, and preparation method and application thereof |
11/21/2013 | WO2013170694A1 Costunolide derivative, pharmaceutical composition thereof as well as preparation method and use thereof |
11/21/2013 | WO2013170385A1 Oligonucleotide chelate complex methods |
11/21/2013 | WO2013142449A9 Treatment for chronic pain syndromes |
11/21/2013 | WO2013106577A3 Enhancement of transport of therapeutic molecules across the blood brain barrier |
11/21/2013 | US20130310388 Modulators of TNF-Alpha Signaling |
11/21/2013 | US20130310336 Methods and compositions for treating flaviviruses and pestiviruses |
11/21/2013 | US20130310335 Prolonged release bioadhesive therapeutic systems |
11/21/2013 | US20130309303 Opiod Agonist Formulations with Releasable And Sequestered Antagonist |
11/21/2013 | US20130309215 Pharmaceutical composition |
11/20/2013 | EP2664615A1 Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents |
11/20/2013 | EP2663565A2 Heteroaryl compounds and methods of use thereof |
11/20/2013 | EP2663561A1 Novel heterocyclic derivatives and their use in the treatment of neurological disorders |
11/20/2013 | EP2663560A1 Crystalline oxazine derivative and its use as bace inhibitor |
11/20/2013 | EP2663559A1 Oxazine derivatives and their use in the treatment of neurological disorders |
11/20/2013 | EP2519521B1 Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia |
11/20/2013 | EP2491024B1 Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines |
11/20/2013 | EP2430022B1 1,2,4-Triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
11/20/2013 | EP2407451B1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
11/20/2013 | EP2300452B1 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as nk1 receptor antagonists |
11/20/2013 | EP2246338B1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
11/20/2013 | EP2240443B1 Proline analogs as ligands for cannabinoid receptors for the treatment of pain |
11/20/2013 | EP2220029B1 Benzamide compounds and their use as prostaglandin E4 receptor agonists |
11/20/2013 | EP2202227B1 Novel histidine derivative |
11/20/2013 | EP2190849B1 4-(9-(3,3-difluorocyclopentyl)-5,7,7-trimethyl-6-oxo-6,7,8,9-tetrahydro-5h-pyrimido[4,5-b[1,4]diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases |
11/20/2013 | EP2146572B1 Bicyclic anilide heterocyclic cgrp receptor antagonists |
11/20/2013 | EP2108655B1 Immune-modulating peptide |
11/20/2013 | EP2091943B1 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
11/20/2013 | EP2085078B1 Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof |
11/20/2013 | EP2036566B1 Use of 20(s)-protopanoxadiol in manufacture of antidepressants |
11/20/2013 | EP1827412B1 Compositions for use in surgery |
11/20/2013 | EP1765805B1 Cgrp receptor antagonists |
11/20/2013 | EP1709009B1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
11/20/2013 | EP1613628B1 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
11/20/2013 | CN203291214U Tobacco control active peptide polymerization liquid steam state cigarette |
11/20/2013 | CN1809645B Method for detecting alzheimer's disease |
11/20/2013 | CN103403010A Inhibitors of polo-like kinase |
11/20/2013 | CN103403007A 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE) |
11/20/2013 | CN103403004A Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels |
11/20/2013 | CN103403003A Bridged piperidine derivatives |
11/20/2013 | CN103403001A Novel heterocyclic derivatives and their use in the treatment of neurological disorders |
11/20/2013 | CN103402994A Heteroaryl derivatives as alpha7 NACHR modulators |
11/20/2013 | CN103402993A Novel esters of 4,9-dihydroxy-naphtho[2,3-b]furans for disease therapies |
11/20/2013 | CN103402986A Modulators of S1P receptors |
11/20/2013 | CN103402983A (Pyridin-4-yl)benzylamides as allosteric modulators of alpha 7 NACHR |
11/20/2013 | CN103402535A Use of ICAM-1 for prevention or treatment of neurological diseases |
11/20/2013 | CN103402524A Concomitant drug for improving cognitive function |
11/20/2013 | CN103402514A Combinations of serotonin receptor agonists for treatment of movement disorders |
11/20/2013 | CN103402511A Novel benzodioxole piperidine compounds |
11/20/2013 | CN103402499A Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
11/20/2013 | CN103402376A Human milk oligosaccharides to promote growth of beneficial bacteria |
11/20/2013 | CN103396993A Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
11/20/2013 | CN103396489A Engineered anti-IL-23p19 antibodies |
11/20/2013 | CN103396485A Method and composition for targeting polyubiquitin |
11/20/2013 | CN103396462A Curcumin glucoside and preparation method and application thereof in treating Parkinson disease |
11/20/2013 | CN103396415A Novel substituted imidazoquinolines |
11/20/2013 | CN103396412A Modifier of 5-HT2A serotonin receptor |
11/20/2013 | CN103396409A Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
11/20/2013 | CN103396399A Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising same |
11/20/2013 | CN103396328A Meclofenoxate hydrochloride compound and pharmaceutical composition thereof |
11/20/2013 | CN103396302A Alpha-cyperone and preparation method of preparation thereof |
11/20/2013 | CN103394090A Opioids for treatment of restless leg syndrome (RLS) |
11/20/2013 | CN103394087A Dosage form time-lagged of drugs for therapy of insomnia |
11/20/2013 | CN103394064A Traditional Chinese medicine composition used for treating slight cold |
11/20/2013 | CN103394055A Traditional Chinese medicine containing nux vomica powder and preparation method thereof |
11/20/2013 | CN103394038A Medicine for treating anxiety |
11/20/2013 | CN103394033A Traditional Chinese medicine preparation for treating nervous headache |
11/20/2013 | CN103394031A Medicament for treating sciatica |
11/20/2013 | CN103394029A Traditional Chinese medicine for treating severe insomnia after cerebral apoplexy |
11/20/2013 | CN103393994A Medicine for treating diabetic foot |
11/20/2013 | CN103393982A Nerve calming liquid |
11/20/2013 | CN103393967A Traditional Chinese medicine ointment used for smoking cessation |
11/20/2013 | CN103393959A Blood lipid-lowering traditional Chinese medicine formulation and preparation method thereof |
11/20/2013 | CN103393957A Drug for treatment of liver-yang headache |
11/20/2013 | CN103393954A Preparation method of ointment for helping rehabilitation of peroneal nerve injury |
11/20/2013 | CN103393941A Drug for treating cerebral infarction |
11/20/2013 | CN103393931A Traditional Chinese medicine liquor |
11/20/2013 | CN103393930A Preparation method for heart-yin nourishing preparation |
11/20/2013 | CN103393863A Traditional Chinese medicine for treating peripheral facial paralysis |
11/20/2013 | CN103393862A Chinese medicinal composition for treating lumbocrural pain |
11/20/2013 | CN103393860A Traditional Chinese medicine composition for treating hyperactivity of liver-yang |
11/20/2013 | CN103393850A Drug for median nerve injury |
11/20/2013 | CN103393849A Oral liquid for nursing hair loss patient and preparation method |
11/20/2013 | CN103393848A Medicinal liquor and preparation method thereof |
11/20/2013 | CN103393837A External medicine for curing radial nerve palsies |
11/20/2013 | CN103393836A Preparation method of paste for curing paralysis of the radial nerve |
11/20/2013 | CN103393831A Chinese medicine composition for treating vascular dementia and preparation and application thereof |
11/20/2013 | CN103393825A Traditional Chinese medicine for treating catatonic headache and preparation method thereof |
11/20/2013 | CN103393809A Medicine for treating Parkinson |
11/20/2013 | CN103393792A Medicine for treating sciatica |
11/20/2013 | CN103393784A Traditional Chinese medicine formulation for treating neurodermatitis and preparing method thereof |
11/20/2013 | CN103393782A Traditional Chinese medicine composition with function of resolving stagnation for tranquilization, preparation and preparation method thereof |
11/20/2013 | CN103393781A Cardiovascular healthcare medicine |
11/20/2013 | CN103393757A Traditional Chinese medicine decoction for treating radioactive brain damage |
11/20/2013 | CN103393742A Gynostemma pentaphyllum (thunb) makino effective fraction and application thereof |
11/20/2013 | CN103393740A Application of frankincense extract in prevention and treatment of cardio-cerebral-vascular disease or liver and kidney injury |